Workflow
Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker.
辉瑞辉瑞(US:PFE) Barrons·2025-10-30 19:11

Denmark's Novo offers 56.50ashareincashforMetsera,pluspotentiallyafurther56.50 a share in cash for Metsera, plus potentially a further 21.25 a share based on clinical and regulatory milestones. ...